Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.605 USD | -2.04% | +0.42% | -0.96% |
May. 14 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
May. 14 | HealthEquity Completes Acquisition of Conduent's BenefitWallet | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For several months, analysts have been revising their EPS estimates roughly upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.82% | 753M | B | ||
+9.39% | 37.28B | B+ | ||
+2.00% | 15.42B | C- | ||
-7.12% | 8.91B | B | ||
-1.45% | 6.99B | C | ||
+11.46% | 5.3B | B+ | ||
-49.39% | 4.16B | - | - | |
+11.04% | 2.95B | D | ||
-21.23% | 2.15B | - | C | |
-12.22% | 2.14B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CNDT Stock
- Ratings Conduent Incorporated